AI-generated summary
The authors evaluated far infrared radiation (FIR), a form of heat-based therapy, in 32 patients with stage II or III extremity lymphedema treated between January 2015 and January 2016. They report reduced limb circumference, improved quality of life, and lower measured levels of fluid, fat, protein and hyaluronan. The abstract does not describe a control group, so the findings cannot be separated from other influences.
- Participants
- 32
- Who or what was studied
- Patients with stage II and III extremity lymphedema treated between January 2015 and January 2016
- Limits stated in the abstract
- The abstract does not describe a control group or the wavelengths used, and the study size and design are not detailed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Far-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.